Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The PulsePoint Study is a research trial designed to see if a new system called PulsePoint can help increase the number of people who perform CPR or use a defibrillator when someone has a cardiac arrest outside of a hospital. In this study, half of the emergency calls for suspected cardiac arrest in public places will receive alerts through the PulsePoint system, while the other half will follow the usual emergency response procedures. The goal is to determine if the PulsePoint alerts lead to more people helping in these critical situations.
To participate in the trial, individuals must be involved in a 911 call that reports a suspected or confirmed cardiac arrest in a public location, where emergency medical services (EMS) are called to help. Unfortunately, those experiencing a cardiac arrest due to trauma, in dangerous situations, or in nursing homes and healthcare facilities won’t be eligible. If you or a loved one are in a situation where this study applies, the research team will provide more information about what being part of the study entails, including any support you’ll receive. This trial is currently looking for participants and welcomes individuals of all ages and genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with 911 calls assigned as "suspected" or "confirmed" cardiac arrest and,
- • 2. Are confirmed to be EMS-treated, public location out-of-hospital cardiac arrest.
- Exclusion Criteria:
- • 1. Traumatic cardiac arrest, or
- • 2. Cardiac arrests occurring in the context of a dangerous scene as determined by the 9-1-1 call-taker, or
- • 3. EMS-witnessed cardiac arrest, or
- • 4. Cardiac arrests not treated by EMS ("Do Not Resuscitate", signs of obvious death), or
- • 5. Cardiac arrests occurring in nursing homes and health care facilities.
About Dr. Steven Brooks
Dr. Steven Brooks is a distinguished clinical trial sponsor with extensive expertise in the design and management of innovative research studies. With a strong background in clinical medicine and a commitment to advancing healthcare through rigorous scientific inquiry, Dr. Brooks oversees a portfolio of trials that focus on developing novel therapies and improving patient outcomes. His collaborative approach fosters partnerships with leading research institutions and healthcare professionals, ensuring adherence to the highest ethical standards and regulatory compliance. Dr. Brooks is dedicated to translating research findings into practical applications that benefit patients and enhance the overall quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Vancouver, British Columbia, Canada
Winnipeg, Manitoba, Canada
Patients applied
Trial Officials
Steven C Brooks, MD MHSc
Principal Investigator
Queen's University
John M Tallon, MD MSc
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials